Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Aquestive Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 121 | 1 | 117 | −3 |
| Shares | 44.3M | 218.4K | 47.6M | +3.57M (+8.1%) |
| Value | $127.8M | $633.3K | $157.6M | +$30.5M (+24.0%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Financial Engines Advisors L.L.C. | 272,686 | $903.0K | 0.00% |
| Gsa Capital Partners LLP | 186,692 | $618.0K | 0.04% |
| Diametric Capital, LP | 165,373 | $547.4K | 0.29% |
| LPL Financial LLC | 77,888 | $257.8K | 0.00% |
| Marshall Wace, LLP | 72,579 | $240.2K | 0.00% |
| Jane Street Group, LLC | 65,618 | $217.2K | 0.00% |
| Centiva Capital, LP | 63,951 | $211.7K | 0.01% |
| Simplex Trading, LLC | 51,546 | $170.0K | 0.00% |
| Squarepoint Ops LLC | 26,034 | $86.2K | 0.00% |
| Daymark Wealth Partners, LLC | 17,500 | $57.9K | 0.00% |
| First National Bank & Trust Co of Newtown | 15,000 | $49.5K | 0.01% |
| Modern Wealth Management, LLC | 10,000 | $33.1K | 0.00% |
| USAdvisors Wealth Management, LLC | 10,000 | $33.0K | 0.01% |
| Northwestern Mutual Wealth Management Co | 1,200 | $3.97K | 0.00% |
| IFP Advisors, Inc | 0 | $2.03K | 0.00% |
| Essential Partners LLC | 47 | $156 | 0.00% |
Sold out (19)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| ExodusPoint Capital Management, LP | 189,177 | $549.0K |
| Dauntless Investment Group, LLC | 91,540 | $265.5K |
| Aquatic Capital Management LLC | 64,909 | $188.2K |
| Financial Advocates Investment Management | 51,000 | $147.9K |
| Levin Capital Strategies, L.P. | 45,000 | $130.5K |
| Corebridge Financial, Inc. | 36,382 | $105.5K |
| Mariner, LLC | 26,316 | $76.3K |
| Trust Point Inc. | 23,396 | $67.8K |
| Susquehanna Portfolio Strategies, LLC | 20,531 | $59.5K |
| Ancora Advisors, LLC | 20,000 | $58.0K |
| Virtu Financial LLC | 20,075 | $58.0K |
| HRT Financial LP | 16,048 | $46.0K |
| Picton Mahoney Asset Management | 3,073 | $8.00K |
| Comprehensive Financial Planning, Inc. | 1,000 | $2.90K |
| Quantbot Technologies LP | 851 | $2.47K |
| Parkside Financial Bank & Trust | 185 | $536 |
| CoreCap Advisors, LLC | 183 | $531 |
| Quadrant Capital Group LLC | 168 | $488 |
| Stonepine Capital Management, LLC | 200,000 | – |
Not filed for Q2 2025 yet (1)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Cahill Wealth Management, LLC | 218,381 | $633.3K |